Your browser doesn't support javascript.
loading
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
Seymour, John F; Marcus, Robert; Davies, Andrew; Gallop-Evans, Eve; Grigg, Andrew; Haynes, Andrew; Herold, Michael; Illmer, Thomas; Nilsson-Ehle, Herman; Sökler, Martin; Dünzinger, Ulrich; Nielsen, Tina; Launonen, Aino; Hiddemann, Wolfgang.
Afiliação
  • Seymour JF; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Victoria, Australia john.seymour@petermac.org.
  • Marcus R; Kings College Hospital, London, UK.
  • Davies A; Cancer Research UK Centre, University of Southampton, UK.
  • Gallop-Evans E; Velindre Cancer Centre, Cardiff, UK.
  • Grigg A; Austin Hospital, Melbourne, Victoria, Australia.
  • Haynes A; Nottingham University Hospitals NHS Trust, UK.
  • Herold M; HELIOS-Klinikum Erfurt, Germany.
  • Illmer T; BAG Freiberg-Richter, Jacobasch, Illmer and Wolf, Dresden, Germany.
  • Nilsson-Ehle H; Section of Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Sökler M; Eberhard-Karls-University Tübingen, Germany.
  • Dünzinger U; Roche Pharma AG, Grenzach-Wyhlen, Germany.
  • Nielsen T; F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Launonen A; F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Hiddemann W; Department of Medicine III, Ludwig-Maximilians-University, Munich, Germany.
Haematologica ; 104(6): 1202-1208, 2019 06.
Article em En | MEDLINE | ID: mdl-30573503

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Revista: Haematologica Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Revista: Haematologica Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália